Navigation Links
Cancer-fighting agent heads for clinical trials

Wauwatosa, Wis. - Now that Christopher Chitambar, a physician researcher at the Medical College of Wisconsin Cancer Center, has found that a gallium compound might be an effective anti-tumor agent, it's time for the test.

If the compound is found to be safe and effective in forthcoming clinical trials, it could treat forms of non-Hodgkin's lymphoma ......

Full article >>> ddress iron-dependent malignant cell growth and to improve the efficacy of cancer chemotherapy by interrupting the flow of iron and other metals within cells.

At the moment, the cellular basis for tumor cell resistance to gallium nitrate is not well understood, but Chitambar's research has found gallium maltolate to be a unique formulation that bypasses the cellular pathways involved in g......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 12/07/06


Related biology technology :

1. Brilliant Core Reagent Kits for QPCR and QRT-PCR
2. A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines
3. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
4. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
5. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
6. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
7. TransMessenger Transfection Reagent
8. Effectene Transfection Reagent provides efficient gene delivery to primary neuronal cell cultures
9. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
10. Effectene Transfection Reagent
11. PolyFect Transfection Reagent
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
Breaking Biology News(10 mins):